AtriCure, Inc. (NASDAQ:ATRC) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure’s First Quarter 2025 Earnings Conference Call. This call is being recorded for replay purposes.
Posts Tagged ‘(NASDAQ:ATRC)’
AtriCure, Inc. (NASDAQ:ATRC) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure's Fourth Quarter and Full Year 2024 Earnings Conference Call. This call is being recorded for replay purposes.
Why These 15 Stocks Are Skyrocketing in 2025
The market has started to favor smaller companies in 2025, and stocks between $1 billion and $5 billion in market value are attracting renewed interest.
AtriCure, Inc. (NASDAQ:ATRC) Q3 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome to AtriCure's Third Quarter 2024 Earnings Conference Call. This call is being recorded for replay purposes.
Here’s Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC)
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2024 investor letter.
AtriCure, Inc. (NASDAQ:ATRC) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, And welcome to AtriCure's Second Quarter 2024 Earnings Conference Call. This call is being recorded for replay purposes.
AtriCure (ATRC) Stock Slipped on Competition Threat
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter.
AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to AtriCure’s First Quarter 2024 Earnings Conference Call. This call is being recorded for replay purposes.
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter investor letter.
AtriCure (ATRC) Fell on Competitor Action
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2023 investor letter.
AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript
AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.22. AtriCure, Inc.
AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure’s Third Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
AtriCure, Inc. (NASDAQ:ATRC) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure's Second Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
AtriCure, Inc. (NASDAQ:ATRC) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure's First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
12 Most Promising Medical Stocks According to Analysts
In this article, we will take a look at the 12 most promising medical stocks according to analysts.
AtriCure, Inc. (NASDAQ:ATRC) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure's Q4 2022 Earnings Conference Call. My name is Amy, and I will be your coordinator for the call today.
Alger Capital Believes that AtriCure (ATRC) is Well-Positioned in the Atrial Fibrillation Market
Alger Capital, an investment management company, released its “Alger Small Cap Focus Fund” second quarter investor letter. A copy of the same can be downloaded here.
AtriCure Inc. (ATRC) Fell Out Of Favor With Hedge Funds?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Is AtriCure Inc. (ATRC) Going to Burn These Hedge Funds?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
Billionaire Ray Dalio’s Thoughts on Bitcoin and 10 New Stocks in Portfolio
In this article, we discuss the 10 new stocks in the portfolio of billionaire Ray Dalio.
Is ATRC A Good Stock To Buy Now According To Hedge Funds?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity...
Do Hedge Funds Love AtriCure Inc. (ATRC)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
AtriCure Inc. (ATRC): Were Hedge Funds Right About Buying This Stock?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Are Buying AtriCure Inc. (ATRC)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Hedge Fund and Insider Trading News: Ray Dalio, Ken Griffin, Kyle Bass, Third Point LLC, Polar Capital, AtriCure Inc. (ATRC), SJW Group (SJW), and More
During a White House ceremony Wednesday to sign a first-round trade pact with China, President Donald Trump thanked a long list of elected leaders and called out the names of ...
Hedge Fund and Insider Trading News: Bill Ackman, Tom Steyer, Lime Asset Management, Conagra Brands Inc (CAG), AtriCure Inc. (ATRC), and More
Bill Ackman's hedge fund is on track to land massive returns after three years of negative net performance.
Hedge Fund and Insider Trading News: Tom Steyer, PointState Capital, Renaissance Technologies, Hindsight Capital, Terex Corporation (TEX), NVIDIA Corporation (NVDA), and More
The pain kept coming for hedge funds in 2019: if they weren’t being killed off, they were bleeding cash or wringing out dismal returns.
Did Hedge Funds Drop The Ball On AtriCure Inc. (ATRC) ?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Is AtriCure Inc. (ATRC) A Good Stock To Buy ?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Hedge Funds Have Never Been This Bullish On AtriCure Inc. (ATRC)
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the ...
Hedge Funds Have Never Been More Bullish On AtriCure Inc. (ATRC)
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows their positions at the...
Hedge Funds Are Crazy About AtriCure Inc. (ATRC)
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
Douglas Braunstein’s Hudson Executive Capital Selling Atricure Inc. (ATRC)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of...
AtriCure Inc. (ATRC) Hedge Funds Are Snapping Up
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions...
The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What It’s Betting On in 2016
Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few people have heard its name...
What Do Hedge Funds Think of AtriCure Inc. (ATRC)?
The worries about the economic slowdown in China and the ongoing uncertainty about the path of interest-rate increases triggered several waves of equity sell-offs during the third...
Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds' portfolio at the end of March.
This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)
Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm from smart money lately.
AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?
In today’s marketplace, there are tons of indicators market participants can use to monitor the equity markets.
BIOLASE Inc (BIOL) Shareholders: Have You Seen This Crucial Data?
BIOLASE Inc (NASDAQ:BIOL) was in 4 hedge funds' portfolio at the end of the fourth quarter of 2012.
AtriCure Inc. (ATRC): Insiders Aren’t Crazy About It
AtriCure Inc. (NASDAQ:ATRC) was in 7 hedge funds' portfolio at the end of the fourth quarter of 2012.
